Publications

Publications (2022 - 1976)

Source: Web of Science
  1. Rožmanić C, Lisnić B, Pribanić Matešić M, Mihalić A, Hiršl L, Park E, Lesac Brizić A, Indenbirken D, Viduka I, Šantić M, Adler B, Yokoyama WM, Krmpotić A, Juranić Lisnić V, Jonjić S, Brizić I. Perinatal murine cytomegalovirus infection reshapes the transcriptional profile and functionality of NK cells. Nature Communications. 2023 Oct 12;14(1):6412. doi: 10.1038/s41467-023-42182-w. PMID: 37828009; PMCID: PMC10570381.
  2. Khaleafi R, Zeleznjak J, Cordela S, Drucker S, Rovis TL, Jonjic S, Bar-On Y. Reovirus infection of tumor cells reduces the expression of NKG2D ligands, leading to impaired NK-cell cytotoxicity and functionality. Front in Immunology. 2023 Sep 11;14:1231782. doi: 10.3389/fimmu.2023.1231782. PMID: 37753084; PMCID: PMC10518469.
  3. Worboys JD, Vowell KN, Hare RK, Ambrose AR, Bertuzzi M, Conner MA, Patel FP, Zammit WH, Gali-Moya J, Hazime KS, Jones KL, Rey C, Jonjic S, Rovis TL, Tannahill GM, Cruz De Matos GDS, Waight JD, Davis DM. TIGIT can inhibit T cell activation via ligation-induced nanoclusters, independent of CD226 co-stimulation. Nature Communications. 2023 Aug 18;14(1):5016. doi: 10.1038/s41467-023-40755- 3. PMID: 37596248; PMCID: MC10439114
  4. Lodha M, Muchsin I, Jürges C, Juranic Lisnic V, L’Hernault A, Rutkowski AJ, Prusty BK, Grothey A, Milic A, Hennig T, Jonjic S, Friedel CC, Erhard F, Dölken L. Decoding murine cytomegalovirus. PLoS Pathogens. 2023 May 12;19(5):e1010992. doi: 10.1371/journal.ppat.1010992. PMID: 37172056; PMCID: PMC10208470.
  5. Le-Trilling VTK, Jagnjić A, Brizić I, Eilbrecht M, Wohlgemuth K, Rožmanić C, Herdman A, Hoffmann K, Westendorf AM, Hengel H, Jonjić S, Trilling M. Maternal antibodies induced by a live attenuated vaccine protect neonatal mice from cytomegalovirus. NPJ Vaccines. 2023 Feb 3;8(1):8. doi: 10.1038/s41541-023-00602- 4. PMID: 36737485; PMCID: PMC9898546.
  6. Herb S, Zeleznjak J, Hennig T, L’Hernault A, Lodha M, Jürges C, Trsan T, Juranic Lisnic V, Jonjic S, Erhard F, Krmpotic A, Dölken L. Two murine cytomegalovirus microRNAs target the major viral immediate early 3 gene. Journal of General Virology, 103(11). doi: 10.1099/jgv.0.001804. 2022
  7. Brlić PK, Pavletić M, Lerga M, Krstanović F, Matešić MP, Miklić K, Malić S, Mikša L, Pajcur M, Peruč D, Schubert M, Bertoglio F, Arapović J, Protić A, Šustić A, Milošević M, Šain LČ, Jonjić S, Lisnić VJ, Brizić I. SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study. Viruses, 14(9):1966. doi: 10.3390/v14091966. 2022
  8. Brizić I, Lisnić B, Krstanović F, Brune W, Hengel H, Jonjić S. Mouse Models for Cytomegalovirus Infections in Newborns and Adults. Current Protocols, 2(9):e537.doi: 10.1002/cpz1.537. 2022
  9. Borst EM, Harmening S, Sanders S, Caragliano E, Wagner K, Lenac Roviš T, Jonjić S, Bosse JB, Messerle M. A Unique Role of the Human Cytomegalovirus Small Capsid Protein in Capsid Assembly. mBio, e0100722. doi: 10.1128/mbio.01007-22. 2022
  10. Zubković A, Žarak I, Ratkaj I, Rokić F, Jekić M, Pribanić Matešić M, Lebrón R, Gómez-Martín C, Lisnić B, Lisnić VJ, Jonjić S, Pan D, Vugrek O, Hackenberg M, Jurak I. The Virus-Induced Upregulation of the miR-183/96/182 Cluster and the FoxO Family Protein Members Are Not Required for Efficient Replication of HSV-1. Viruses, 14(8):1661. doi: 10.3390/v14081661. 2022
  11. Chaouat AE, Brizic I, Kucan Brlic P, Atari N, Kliker L, Alfi O, Mandelboim M, Wolf D, Tafish L, Kol I, Jonjic S, Mandelboim O. Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern. iScience, 25(9):104935. doi: 10.1016/j.isci.2022.104935. 2022
  12. Ynga-Durand M, Maaß H, Milošević M, Krstanović F, Pribanić Matešić M, Jonjić S, Protić A, Brizić I, Šustić A, Čičin-Šain L. SARS-CoV-2 Viral Load in the Pulmonary Compartment of Critically Ill COVID-19 Patients Correlates with Viral Serum Load and Fatal Outcomes. Viruses, 14;14(6):1292. doi: 10.3390/v14061292. 2022
  13. Zaffran I, Landolina N, Gaur P, Rovis TL, Stipan J, Mandelboim O, Singer BB, Levi-Schaffer F. Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells. Cancer Gene Therapy, 29(11):1676-1685. doi: 10.1038/s41417-022-00486-x. 2022
  14. Cokaric Brdovcak M, Materljan J, Sustic M, Ravlic S, Ruzic T, Lisnic B, Miklic K, Brizic I, Pribanic Matesic M, Juranic Lisnic V, Halassy B, Roncevic D, Knezevic Z, Stefan L, Bertoglio F, Schubert M, Cicin-Sain L, Markotic A, Jonjic S, Krmpotic A. ChAdOx1-S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination. European Journal of Immunology, 52(6):936-945. doi: 10.1002/eji.202249823. 2022
  15. Pribanic Matesic M, Kucan Brlic P, Lenac Rovis T, Macak Safranko Z, Chaouat AE, Miklic K, Malic S, Ivankovic N, Schubert M, Bertoglio F, Markotic A, Mandelboim O, Jonjic S, Brizic I. Collection of Monoclonal Antibodies Targeting SARS-CoV-2 Proteins. Viruses, 21;14(2):443. doi: 10.3390/v14020443. 2022
  16. Kim Y, Zheng X, Eschke K, Chaudhry MZ, Bertoglio F, Tomic A, Krmpotic A, Hoffmann M, Bar-On Y, Boehme J, Bruder D, Ebensen T, Brunotte L, Ludwig S, Messerle M, Guzman C, Mandelboim O, Hust M, Pohlmann S, Jonjic S, Cicin-Sain L. MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination. Cellular & Molecular Immunology, 19(2):234-244. doi: 10.1038/s41423-021-00814-5. 2022
  17. Ravlic S, Brgles M, Hirsl L, Jonjic S, Halassy B. Production- and Purification-Relevant Properties of Human and Murine Cytomegalovirus. Viruses, 13(12):2481. doi: 10.3390/v13122481. 2021
  18. Chaouat AE, Achdout H, Kol I, Berhani O, Roi G, Vitner EB, Melamed S, Politi B, Zahavy E, Brizic I, Lenac Rovis T, Alfi O, Wolf D, Jonjic S, Israely T, Mandelboim O. SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection. PLoS Pathogens, 17(12):e1010175. doi: 10.1371/journal.ppat.1010175. 2021
  19. Pietri GP, Tontini M, Brogioni B, Oldrini D, Robakiewicz S, Henriques P, Calloni I, Abramova V, Santini L, Malić S, Miklić K, Lisnic B, Bertuzzi S, Unione L, Balducci E, de Ruyck J, Romano MR, Jimenez-Barbero J, Bouckaert J, Jonjic S, Rovis TL, Adamo R. Elucidating the Structural and Minimal Protective Epitope of the Serogroup X Meningococcal Capsular Polysaccharide. Frontiers in Molecular Biosciences, 8:745360. doi: 10.3389/fmolb.2021.745360. 2021
  20. Šustić M, Cokarić Brdovčak M, Krmpotić A, Jonjić S. CD8 T Cell Vaccines and a Cytomegalovirus-Based Vector Approach. Life (Basel), 11(10):1097. doi: 10.3390/life11101097. 2021
  21. Ružić T, Lisnić VJ, Lučin HM, Roviš TL, Železnjak J, Brdovčak MC, Vrbanović A, Oreb D, Kveštak D, Jerčić KG, Borovečki F, Lučin P, Adler B, Jonjić S, Lisnić B. Characterization of M116.1p, a murine cytomegalovirus protein required for efficient infection of mononuclear phagocytes. Journal of Virology. doi: 10.1128/JVI.00876-21. 2021
  22. Moulden J, Sung CYW, Brizic I, Jonjic S, Britt W. Murine Models of Central Nervous System Disease following Congenital Human Cytomegalovirus Infections. Pathogens, 10(8):1062. doi: 10.3390/pathogens10081062. 2021
  23. Chan B, Arapović M, Masters LL, Rwandamuiye F, Jonjić S, Smith LM, Redwood AJ: The m15 Locus of Murine Cytomegalovirus Modulates Natural Killer Cell Responses to Promote Dissemination to the Salivary Glands and Viral Shedding. Pathogens, 10(7):866. doi: 10.3390/pathogens10070866. 2021
  24. Berni F, Kalfopoulou E, Gimeno Cardells AM, Carboni F, van der Es D, Romero-Saavedra F, Laverde D, Miklic K, Malic S, Rovis TL, Jonjic S, Ali S, Overkleeft HS, Hokke CH, van Diepen A, Adamo R, Jiménez-Barbero J, van der Marel GA, Huebner J, Codée JDC. Epitope Recognition of a Monoclonal Antibody Raised against a Synthetic Glycerol Phosphate Based Teichoic Acid. ACS Chemical Biology, 16(8):1344-1349. doi: 10.1021/acschembio.1c00422. 2021
  25. Krstanović F, Britt WJ, Jonjić S, Brizić I: Cytomegalovirus Infection and Inflammation in Developing Brain. Viruses, 13(6):1078. doi: 10.3390/v13061078. 2021
  26. Šustić M, Cokarić Brdovčak M, Lisnić B, Materljan J, Juranić Lisnić V, Rožmanić, Indenbirken D, Hiršl L, Busch DH, Brizić I, Krmpotić A, Jonjić S: Memory CD8 T Cells Generated by Cytomegalovirus Vaccine Vector Expressing NKG2D Ligand Have Effector-Like Phenotype and Distinct Functional Features. Frontiers in Immunology, 12:681380. doi: 10.3389/fimmu.2021.681380. 2021
  27. Strazic Geljic I, Kucan Brlic P, Musak L, Karner D, Ambriović‐Ristov A, Jonjic S, Schu P, Lenac Rovis T: Viral Interactions with Adaptor‐Protein Complexes: A Ubiquitous Trait among Viral Species. International Journal of Molecular Sciences, 22(10):5274. doi: 10.3390/ijms22105274. 2021
  28. Tomac J, Mazor M, Lisnić B, Golemac M, Kveštak D, Bralić M, Bilić Zulle L, Brinkmann MM, Dölken L, Reinert LS, Paludan SR, Krmpotić A, Jonjić S, Juranić Lisnić V: Viral infection of the ovaries compromises pregnancy and reveals innate immune mechanisms protecting fertility. Immunity, 54(7):1478-1493.e6. doi: 10.1016/j.immuni.2021.04.020.. 2021
  29. Lisnić B, Tomac J, Cekinović D, Jonjić S, Juranić Lisnić V: Rodent Models of Congenital Cytomegalovirus Infection. Methods in Molecular Biology, doi: 10.1007/978-1-0716-1111-1_18. 2244:365-401. 2021
  30. Kveštak D, Juranić Lisnić V, Lisnić B, Tomac J, Golemac M, Brizić I, Indenbirken D, Cokarić Brdovčak M, Bernardini G, Krstanović F, Rožmanić C, Grundhoff A, Krmpotić A, Britt WJ, Jonjić S: NK/ILC1 cells mediate neuroinflammation and brain pathology following congenital CMV infection. Journal of Experimental Medicine, 218(5):e20201503. doi: 10.1084/jem.20201503. 2021
  31. Angulo G, Zeleznjak J, Martínez-Vicente P, Puñet-Ortiz J, Hengel H, Messerle M, Oxenius A, Jonjic S, Krmpotic A, Engel P, Angulo A: Cytomegalovirus restricts ICOSL expression on antigen presenting cells disabling T cell co-stimulation and contributing to immune evasion. Elife, 10:e59350. doi: 10.7554/eLife.59350. 2021
  32. Ouwendijk W, Depledge D, Rajbhandari L, Lenac-Rovis T, Jonjic S, Breuer J, Venkatesan A, Verjans G, Sadaoka T: Varicella-zoster virus VLT-ORF63 fusion transcript induces broad viral gene expression during reactivation from neuronal latency. Nature Communications, 11(1):6324. doi: 10.1038/s41467-020-20031-42020. 2020
  33. Redwood AJ, Masters LL, Chan B, Leary S, Forbes C, Jonjić S, Juranić Lisnić V, Lisnić B, Smith LM: Repair of an attenuated low passage murine cytomegalovirus bacterial artificial chromosome identifies a novel spliced gene essential for salivary gland tropism. Journal of Virology, 94(22):e01456-20. doi: 10.1128/JVI.01456-20. 2020
  34. Kutle I, Szymanska-de Wijs K, Bogdanow B, Cuvalo B, Steinbrück L, Jonjic S, Wagner K, Niedenthal R, Selbach M, Wiebusch L, Dezeljin M, Messerle M: Murine cytomegalovirus M25 proteins sequester the tumor suppressor protein p53 in nuclear accumulations. Journal of Virology, 94(20):e00574-20. doi: 10.1128/JVI.00574-20. 2020
  35. Ouwendijk WJD, Dekker L, Van den Ham H-J, Lenac Rovis T, Haefner E, Jonjic S, Haas J, Luider TM, Verjans GMGM: Analysis of virus and host proteomes during productive HSV-1 and VZV infection in human epithelial cells. Frontiers in Microbiology, 11:1179. doi: 10.3389/fmicb.2020.01179. 2020
  36. Chaudhry MZ, Casalegno-Garduno R, Sitnik KM, Kasmapour B, Pulm A-K, Brizic I, Eiz-Vesper B, Moosmann A, Jonjic S, Mocarski ES, Cicin-Sain L: Cytomegalovirus Inhibition of Extrinsic Apoptosis Determines Fitness and Resistance to Cytotoxic CD8 T Cells. Proceedings of the National Academy of Sciences of the United States of America, 117(23):12961-12968. doi: 10.1073/pnas.1914667117. 2020
  37. Reches A, Ophir Y, Stein N, Kol I, Isaacson B, Amikam YC, Elnekave A,Tsukerman P, Kucan Brlic P, Lenac T, Seliger B, Jonjic S, Mandelboim O:Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity. Journal for ImmunoTherapy of Cancer, 8:e000266. doi: 10.1136/jitc-2019-000266. 2020
  38. Kavazović I, Han H, Balzaretti G, Slinger E, Lemmermann NAW, Ten Brinke A, Merkler D, Koster J, Bryceson YT, de Vries N, Jonjić S, Klarenbeek PL, Polić B, Eldering E, Wensveen FM.: Eomes broadens the scope of CD8T-cell memory by inhibiting apoptosis in cells of low affinity. PLoS Biology, 18(3):e3000648. doi: 10.1371/journal.pbio.3000648. 2020
  39. Strazic Geljic I, Kucan Brlic P, Angulo G, Brizic I, Lisnic B, Jenus T, Juranic Lisnic V, Pietri GP, Engel P, Kaynan N, Zeleznjak J, Schu P, Mandelboim, O, Krmpotic A, Angulo A, Jonjic S, Lenac Rovis T: Cytomegalovirus protein m154 perturbs the adaptor protein-1 compartment mediating broad-spectrum immune evasion. eLife. 9:e50803. doi: 10.7554/eLife.50803. 2020
  40. Arapović J, Rajič B, Pati S, Brizić I, Azinović I, Šušak B, Ostojić M, Tutiš B, Raguž AB, Tomić V, Jonjić S, Boppana S: Cytomegalovirus Seroprevalence and Birth Prevalence of Congenital CMV Infection in Bosnia and Herzegovina: A Single-Center Experience. The Pediatric Infectious Disease Journal, 39(2):140-144. doi: 10.1097/INF.0000000000002510. 2020
  41. Berry R, Watson G, Jonjic S, Delgi-Esposti M, Rossjohn J: Modulation of Innate and Adaptive Immunity by Cytomegaloviruses. Nature Reviews in Immunology, 20(2):113-127. doi:10.1038/s41577-019-0225-5. 2020
  42. Cossarizza A, Chang HD, Radbruch A … Jonjic S … Zimmermann J, Zychlinsky A (>200): Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). European Journal of Immunology, 49(10):1457-1973. doi: 10.1002/eji.201970107. 2019
  43. Aguilar OA, Sampaio IS, Rahim MMA, Samaniego JD, Tilahun ME, Krishnamoorthy M, Popović B, Babić M, Krmpotić A, Treanor B, Margulies DH, Allan DSJ, Makrigiannis AP, Jonjić S, Carlyle JR: Mouse cytomegalovirus m153 protein stabilizes expression of the inhibitory NKR-P1B ligand, Clr-b. Journal of Virology, 94(1):e01220-19. doi: 10.1128/JVI.01220-19. 2019
  44. Won Sung C, Seleme M, Payne S, Jonjic S, Hirose K, Britt W: Virus-induced cochlear inflammation in newborn mice alters auditory function. The Journal of Clinical Investigation – Insight, 4(17):e128878. doi: 10.1172/jci.insight.128878. 2019
  45. Kalfopoulou E, Laverde D, Miklic K, Saavedra F, Malic S, Carboni F, Adamo R, Lenac Rovis T, Jonjic S, Huebner J: Development of opsonic mouse monoclonal antibodies against multidrug resistant enterococci. Infection and Immunity, 87(9):e00276-19. doi: 10.1128/IAI.00276-19. 2019
  46. Železnjak J, Juranić Lisnić V, Popović B, Lisnić B, Babić M, Halenius A, L’Hernault A, Lenac Roviš T, Hengel H, Erhard F, Redwood A, Vidal S, Doelken l,  Krmpotić A, Jonjić S: The complex of MCMV proteins and MHC class I evades NK cell control and drives the evolution of virus-specific activating Ly49 receptors. Journal of Experimental Medicine, 216(8):1809-1827. doi: 10.1084/jem.20182213. 2019
  47. Pallmer K, Barnstorf I, Baumann N, Borsa M, Jonjic S, Oxenius A: NK cells negatively regulate CD8 T cells via Natural Cytotoxicity Receptor (NCR) 1 during LCMV infection. PLOS Pathogens, 15(4):e1007725. doi:10.1371/journal.ppat.1007725. 2019
  48. Krmpotić A, Podlech J, Reddehase M, Britt W, Jonjić S: Role of antibodies in confining cytomegalovirus after reactivation from latency: three decades’ résumé. Medical Microbiology and Immunology, 208(3-4):415-429. doi:10.1007/s00430-019-00600-1. 2019
  49. Brizić I, Hiršl L, Šustić M, Golemac M, Britt W, Krmpotić A, Jonjić S: CD4 T cells are required for maintenance of CD8 TRM cells and virus control in the brain of MCMV‑infected newborn mice. Medical Microbiology and Immunology, 208(3-4):487-494. doi:10.1007/s00430-019-00601-0. 2019
  50. Gawish R, Bulat T, Biaggio M, Lassnig C, Bago-Horvath Z, Macho-Maschler S, Poelzl A, Simonovic N, Prchal-Murphy M, Rom R, Amenitsch L, Ferrarese L, Kornhoff J, Lederer T, Svinka J, Eferl R, Bosmann M, Kalinke U, Stoiber D, Sexl V, Krmpotic A, Jonjic S, Mueller M, Strobl B: Myeloid Cells Restrict MCMV and Drive Stress-Induced Extramedullary Hematopoiesis through STAT1. Cell Reports, 26(9):2394–2406. doi:10.1016/j.celrep.2019.02.017. 2019
  51. Stojanovic B, Milovanovic J, Arsenijevic A, Strazic Geljic I, Arsenijevic N, Jonjic S, Lukic M, Milovanovic M: Galectin-3 deficiency facilitates TNF-α-dependent hepatocyte death and liver inflammation in MCMV infection. Frontiers in Microbiology, 10:185. doi: 10.3389/fmicb.2019.00185. 2019
  52. Yunis J, Farrell HE, Bruce K, Lawler C, Wyer O, Davis-Poynter N, Brizić I, Jonjić S, Adler B, Stevenson P: Murine Cytomegalovirus glycoprotein O promotes epithelial cell infection in vivo. Journal of Virology, 93(3):e01378-18. doi: 10.1128/JVI.01378-18. 2019
  53. Kučan Brlić P, Lenac Roviš T, Cinamon G, Tsukerman P, Mandelboim O, Jonjić S: Targeting PVR (CD155) and its receptors in anti-tumor therapy. Cellular and Molecular Immunology, 16(1):40-52. doi: 10.1038/s41423-018-0168-y. 2019
  54. Berhani O, Glasner A, Kahlon S, Duev‐Cohen A, Yamin R, Horwitz E, Enk J, Moshel O, Varvak A, Porgador A, Jonjic S, Mandelboim O: Human anti-NKp46 antibody for studies of NKp46-dependent NK cell function and its applications for type 1 diabetes and cancer research. European Journal of Immunology, 49(2):228-241. doi:10.1002/eji.201847611. 2018
  55. Lučin P, Kareluša Lj, Blagojević Zagorac G, Mahmutefendić Lučin H, Pavišić V, Jug Vučko N, Lukanović Jurić S, Marcelić M, Lisnić B, Jonjić S: Cytomegaloviruses Exploit Recycling Rab Proteins in the Sequential Establishment of the Assembly Compartment. Frontiers in Cell and Developmental Biology, 6:165. doi:10.3389/fcell.2018.00165. 2018
  56. Zaytseva OO, Jansen BC, Hanić M, Mrčela M, Razdorov G, Stojković R, Erhardt J, Brizić I, Jonjić S, Pezer M, Lauc G: MIgGGly (mouse IgG glycosylation analysis) – a high-throughput method for studying Fc-linked IgG N-glycosylation in mice with nanoUPLC-ESI-MS. Scientific Reports, 8:13688. doi:10.1038/s41598-018-31844-1. 2018
  57. Brizić I, Lisnić B, Brune W, Hengel H, Jonjić, S: Cytomegalovirus infection: Mouse model. Current Protocols in Immunology, e51. doi: 10.1002/cpim.51. 2018
  58. Šestan M, Marinović S, Kavazović I, Cekinović Đ, Wueest S, Turk Wensveen T, Brizić I, Jonjić S, Konrad D, Wensveen FM, Polić B: Virus-Induced Interferon-γ Causes Insulin Resistance in Skeletal Muscle and Derails Glycemic Control in Obesity. Immunity, 49(1):164-177. doi: 10.1016/j.immuni.2018.05.005. 2018
  59. Hiršl L, Brizić I, Jenuš T, Juranić Lisnić V, Reichel JJ, Jurković S, Krmpotić A, Jonjić S: Murine CMV expressing the high affinity NKG2D ligand MULT-1:a Model for the development of cytomegalovirus-Based Vaccines. Frontiers in Immunology, 9:991. doi: 10.3389/fimmu.2018.00991. 2018
  60. Brizić I, Šušak B, Arapović M, Huszthy PC, Hiršl L, Kveštak D, Lisnić VJ, Golemac M, Pugel EP, Tomac J, Oxenius A, Britt WJ, Arapović J, Krmpotić A, Jonjić S: Brain-resident memory CD8+ T cells induced by congenital CMV infection prevent brain pathology and virus reactivation. European Journal of Immunology, 48(6):950-964. doi: 10.1002/eji.201847526. 2018
  61. Milbradt J, Sonntag E, Wagner S, Strojan H, Wangen C, Lenac Rovis T, Lisnic B, Jonjic S, Sticht H, Britt WJ, Schlötzer-Schrehardt U, Marschall M: Human Cytomegalovirus Nuclear Capsids Associate with the Core Nuclear Egress Complex and the Viral Protein Kinase pUL97. Viruses,  10(1). doi: 10.3390/v10010035. 2018
  62. Brizić I, Hiršl L, Britt WJ, Krmpotić A, Jonjić S: Immune responses to congenital cytomegalovirus infection. Microbes and Infection, 20(9-10):543-551. doi: 10.1016/j.micinf.2017.12.010. 2018
  63. Glasner A, Levi A, Enk J, Isaacson B, Viukov S, Orlanski S, Scope A, Neuman T, Enk CD, Hanna JH, Sexl V, Jonjic S, Seliger B, Zitvogel L, Mandelboim O: NKp46 Receptor-Mediated Interferon-y Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis. Immunity, 48(1):107-119.e4. doi: 10.1016/j.immuni.2017.12.007. 2018
  64. Cossarizza A, Chang HD, Radbruch A…Jonjic S…Zimmermann J (>200): Guidelines for the use of flow cytometry and cell sorting in immunological studies. European Journal of Immunology, 47(10):1584-1797. doi: 10.1002/eji.201646632. 2017
  65. Goodier MR, Jonjić S, Riley EM, Lisnić VJ: CMV and Natural Killer cells: shaping the response to vaccination. European Journal of Immunology, 48(1):50-65. doi: 10.1002/eji.201646762. 2017
  66. Molgora M, Bonavita E, Ponzetta A, Riva F, Barbagallo M, Jaillon S, Popovic B, Bernardini G, Magrini E, Gianni F, Zelenay S, Jonjic S, Santoni A, Garlanda C, Mantovani A: IL-1R8 is a checkpoint in NK cells regulating anti-tumor and anti-viral activity. Nature, 551(7678):110-114. doi:10.1038/nature24293. 2017
  67. Cohrs RJ, Lee KS, Beach A, Sanford B, Baird NL, Como C, Graybill C, Jones D, Tekeste E, Ballard M, Chen X, Yalacki D, Frietze S, Jones K, Lenac Rovis T, Jonjić S, Haas J, Gilden D: Targeted Genome Sequencing Reveals Varicella-Zoster Virus Open Reading Frame 12 Deletion. Journal of Virology, 91(20):e01141-17. doi: 10.1128/JVI.01141-17. 2017
  68. Nabekura T, Gotthardt D, Niizuma K, Trsan T, Jenus T, Jonjic S, Lanier LL: Cutting Edge: NKG2D Signaling Enhances NK Cell Responses but Alone Is Insufficient To Drive Expansion during Mouse Cytomegalovirus Infection. Journal of Immunology, 199(5):1567-1571. doi: 10.4049/jimmunol.1700799. 2017
  69. Chaudhry MZ, Kasmapour B, Plaza-Sirvent C, Bajagic M, Casalegno Garduño R, Borkner L, Lenac Rovis T, Scrima A, Jonjic S, Schmitz I, Cicin-Sain L: UL36 Rescues Apoptosis Inhibition and In vivo Replication of a Chimeric MCMV Lacking the M36 Gene. Frontiers in Cellular and Infection Microbiology, 7:312. doi.org/10.3389/fcimb.2017.00312. 2017
  70. Miletic A, Lenartic M, Popovic B, Brizic I, Trsan T, Miklic K, Mandelboim O, Krmpotic A, Jonjic S: NCR1-deficiency diminishes the generation of protective murine cytomegalovirus antibodies by limiting follicular helper T-cell maturation. European Journal of Immunology, 47(9):1443-1456. doi: 10.1002/eji.201646763. 2017
  71. Tršan T, Vuković K, Filipović P, Brizić AL, Lemmermann NAW, Schober K, Busch DH, Britt WJ, Messerle M, Krmpotić A, Jonjić S: Cytomegalovirus vector expressing RAE-1γ induces enhanced anti-tumor capacity of murine CD8+ T cells. European Journal of Immunology, 47(8):1354–1367. doi: 10.1002/eji.201746964. 2017
  72. Hirche C, Frenz T, Haas SF, Döring M, Borst K, Tegtmeyer PK, Brizic I, Jordan S, Keyser K, Chhatbar C, Pronk E, Lin S, Messerle M, Jonjic S, Falk CS, Trumpp A, Essers MAG, Kalinke U: Systemic Virus Infections Differentially Modulate Cell Cycle State and Functionality of Long-Term Hematopoietic Stem Cells In Vivo. Cell Reports, 19(11):2345-2356. doi: 10.1016/j.celrep.2017.05.063. 2017
  73. Chan B, Gonçalves Magalhães VG, Lemmermann NAW,  Juranić Lisnić V, Stempel M,  Bussey KA,  Reimer E,  Podlech J, Lienenklaus S,  Reddehase MJ,  Jonjić S,  Brinkmann MM: The murine cytomegalovirus M35 protein antagonizes type I IFN induction downstream of pattern recognition receptors by targeting NF-κB mediated transcription. PLOS Pathogens, 13(5): e1006382. doi: 10.1371/journal.ppat.1006382. 2017
  74. Zeleznjak J, Popovic B, Krmpotic A, Jonjic S, Lisnic VJ: Mouse cytomegalovirus encoded immunoevasins and evolution of Ly49 receptors – Sidekicks or enemies? Immunology Letters, 189:40-47. doi: 10.1016/j.imlet.2017.04.007. 2017
  75. Kavazovic I, Lenartic M, Jelencic V, Jurkovic S, Lemmermann NA, Jonjic S, Polic B, Wensveen FM: NKG2D stimulation of CD8+ T cells during priming promotes their capacity to produce cytokines in response to viral infection in mice. European Journal of Immunology, 47(7):1123-1135. doi: 10.1002/eji.201646805. 2017
  76. Popovic B, Golemac M, Podlech J, Zeleznjak J, Bilic-Zulle L, Lukic M, Cicin-Sain L, Reddehase M, Sparwasser T, Krmpotic A, Jonjic S: IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection. PLOS Pathogens, 13(4):e1006345. doi: 10.1371/journal.ppat.1006345. 2017
  77. González-Motos V, Ritter B, Jürgens C, Kropp KA, Duran E, Larsen O, Ouwendijk WJD, Lenac Rovis T, Jonjic S, Verjans GMG, Sodeik B, Krey T, Bauerfeind R, Schulz TF, Kaufer BB, Kalinke U, Proudfoot AEI, Rosenkilde MM, Viejo-Borbolla A: Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration. PLOS Pathogens, 13(5):e1006346. doi: 10.1371/journal.ppat.1006346. 2017
  78. Aguilar AO, Berry R, Rahim MMA, Reichel JJ, Popovic B, Tanaka M, Fu Z, Balaji GR, Lau TNH, Tu MM, Kirkham CL, Mahmoud AB, Mesci A, Krmpotic A, Allan DSJ, Makrigiannis AP, Jonjic S, Rossjohn J, Carlyle JR: A Viral Immunoevasin Controls Innate Immunity by Targeting the Prototypical Natural Killer Cell Receptor Family. Cell, 169(1):58-71.e14. doi: 10.1016/j.cell.2017.03.002. 2017
  79. Diab M, Glasner A, Issacson B, Bar-On Y, Drori Y, Yamin R, Duev-Cohen A, Danziger O, Zamostiano R, Mandelboim M, Jonjic S, Bacharach E, Mandelboim O: NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection. European Journal of Immunnology, 47(4):692-703. doi: 10.1002/eji.201646756. 2017
  80. Milovanović J, Popović B, Milovanović M, Kveštak D, Arsenijević A, Stojanović B, Tanasković I, Krmpotić A,  Arsenijević N, Jonjić S, Lukić ML: Murine Cytomegalovirus Infection Induces Susceptibility to EAE in Resistant BALB/C mice. Frontiers in Immunology, 8:192. doi: 10.3389/fimmu.2017.00192. 2017
  81. Seleme M, Kosmac K, Jonjic S, Britt W: Tumor Necrosis Factor Alpha-Induced Recruitment of Inflammatory Mononuclear Cells Leads to Inflammation and Altered Brain Development in Murine Cytomegalovirus-Infected Newborn Mice. Journal of Virology, 91(8). doi: 10.1128/JVI.01983-16. 2017
  82. Tomic A,Varanas PR, Golemac M, Malic S, Riese P, Borst EM, Mischak-Weissinger E,  Guzmán CA, Krmpotić A, Jonjic S, Messerle M: Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathogens, 12(12):e1006015. doi: 10.1371/journal.ppat.1006015. 2016
  83. Thiel N, Keyser KA,  Lemmermann N,  Oduro JD, Wagner K, Elsner C,   Halenius A,  Lenac Rovis T,  Brinkmann M,  Jonjic S,  Cicin-Sain L,  Messerle M: The Mouse Cytomegalovirus Gene m42 Targets Surface Expression of the Protein Tyrosine Phosphatase CD45 in Infected Macrophages. PLoS Pathogens, 12(12):e1006057. doi: 10.1371/journal.ppat.1006057. 2016
  84. Lenac Rovis T,  Kucan Brlic P, Kaynan N, Juranic Lisnic V, Brizic I, Jordan S, Tomic A, Kvestak D, Babic, Tsukerman P, Colonna M, Koszinowski U, Messerle M, Mandelboim O, Krmpotic A, Jonjic S: Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection. Journal of Experimental Medicine, 213(9):1835-50. doi: 10.1084/jem.20151899. 2016
  85. Vitenshtein A, Weisblum Y, Hauka S, Halenius A, Oiknine-Djian E,Tsukerman P, Bauman Y, Bar-On Y, Stern-Ginossar N, Enk J, Ortenberg R, Tai J, Markel G, Blumberg RS, Hengel H, Jonjic S, Wolf DG, Adler H, Kammerer R, Mandelboim O: CEACAM1-Mediated Inhibition of Virus Production. Cell Reports, 15(11):2331–9. doi: 10.1016/j.celrep.2016.05.036. 2016
  86. Sonntag E, Hamilton ST, Bahsi H, Wagner S, Jonjić S, Rawlinson WD, Marschall M, Milbradt J: Cytomegalovirus pUL50 is the multi-interacting determinant of the core nuclear egress complex (NEC) that recruits cellular accessory NEC components. Journal of General Virology, 97(7):1676-85. doi: 10.1099/jgv.0.000495. 2016
  87. Borst EM, Bauerfeind R, Binz A, Stephan T, Neuber S, Wagner K, Steinbrück L, Sodeik B, Lenac Rovis T, Jonjic S, Messerle M: The Essential Human Cytomegalovirus Proteins pUL77 and pUL93 are Structural Components Necessary for Viral Genome Encapsidation. Journal of Virology, 90(13):5860-5875. doi: 10.1128/JVI.00384-16. 2016
  88. Arapović M, Brizić I, Popović B, Jurković S, Jordan S, Krmpotić A, Arapović A, Jonjić S: Intrinsic contribution of perforin to NK cell homeostasis during viral infection. Frontiers in Immunology, 7:133. doi: 10.3389/fimmu.2016.00133. 2016
  89. Houston A, Williams JM, Lenac Rovis T, Shanley DK, O’Riordan RT, Kiely P, Ball M, Barry O, Kelly J, Fanning A, MacSharry J, Mandelboim O, Singer BB, Jonjic S, Moore T: Pregnancy-specific glycoprotein (PSG) expression in normal gastrointestinal tract and in tumours detected with novel monoclonal antibodies. mAbs, 8(3):491-500. doi: 10.1080/19420862.2015.1134410. 2016
  90. Glasner A, Simic H, Miklić K, Roth Z, Berhani O, Khalaila I, Jonjic S, Mandelboim O: Expression, Function, and Molecular Properties of the Killer Receptor Ncr1-Noé. Journal of Immunology, 195(8):3959-69. doi: 10.4049/jimmunol.1501234. 2015
  91. Glasner A, Roth Z, Varvak A, Miletic A, Isaacson B, Bar-On Y, Jonjic S, Khalaila I, Mandelboim O: Identification of putative novel O-glycosylations in the NK killer receptor Ncr1 essential for its activity. Cell Discovery, doi: 10.1038/celldisc.2015.36. 1:15036. 2015
  92. Lisnic B, Juranic Lisnic V, Jonjic S: NK cell interplay with cytomegaloviruses. Current Opinion in Virology, 15:9–18. doi: 10.1016/j.coviro.2015.07.001. 2015
  93. Verweij MC, Wellish M, Whitmer T, Malouli D, Lapel M, Jonjic S,  Haas JG, DeFilippis VR, Mahalingam R, Früh K: Varicella Viruses Inhibit Interferon-Stimulated JAK-STAT Signaling through Multiple Mechanisms. PLoS Pathogens, 11(5):e1004901. doi: 10.1371/journal.ppat.1004901. 2015
  94. Bradford R, Yoo Y, Golemac M,  Pugel E,  Jonjic S,  Britt WJ: Murine CMV-Induced Hearing Loss Is Associated with Inner Ear Inflammation and Loss of Spiral Ganglia Neurons. PLoS Pathogens, 11(4):e1004774. doi: 10.1371/journal.ppat.1004774. 2015
  95. Arapovic J, Arapovic M, Golemac M, Traven L, Tomac J, Rumora D, Razic E, Krmpotic A, Jonjic S: The specific NK cell response in concert with perforin prevents CD8+ T cell‑mediated immunopathology after mouse cytomegalovirus infection. Medical Microbiology and Immunology, 204(3):335-4. doi: 10.1007/s00430-015-0409-y. 2015
  96. Yossef R, Gur C, Shemesh A, Guttman O, Hadad U, Nedvetzki S, Miletic A, Nalbandyan K, Cerwenka A, Jonjic S, Mandelboim O, Porgador A: Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes. Plos One, 10(2):e0118936. doi: 10.1371/journal.pone.0118936. 2015
  97. Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, Shussman N, Almogy G, Cuapio A, Hofer E, Mevorach D, Tabib A, Ortenberg R, Markel G, Miklic K, Jonjic S, Brennan CA, Garrett WS, Bachrach G, Mandelboim O: Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity, 42(2):344-355. doi: 10.1016/j.immuni.2015.01.010. 2015
  98. Jonjic S: CMV Immunology. Cellular and Molecular Immunology, 12(2):125-7. doi: 10.1038/cmi.2014.132. 2015
  99. Lemmermann N, Krmpotic A, Podlech J, Brizic I, Prager A,  Adler H, Karbach A, Wu Y, Jonjic S, Reddehase MJ, Adler B: Non-redundant and redundant roles of cytomegalovirus gH/gL complexes in host organ entry and intra-tissue spread. PLoS Pathogens, 11(2):e1004640. doi: 10.1371/journal.ppat.1004640. 2015
  100. Eifler M, Uecker R, Weisbach H, Bogdanow B, Richter E, König L, Vetter B, Lenac-Rovis T, Jonjic S, Neitzel H, Hagemeier C, Wiebusch L: PUL21a-Cyclin A2 interaction is required to protect human cytomegalovirus-infected cells from the deleterious consequences of mitotic entry. PLoS Pathogens, 10(10):e1004514. doi: 10.1371/journal.ppat.1004514. 2014
  101. Pyzik M, Dumaine AA, Charbonneau B, Fodil-Cornu N, Jonjic S, Vidal SM: Viral MHC class I-like molecule allows evasion of NK cell effector responses in vivo. Journal of Immunology, 193(12):6061-9. doi: 10.4049/jimmunol.1401386. 2014
  102. Gabaev I, Elbasani E, Ameres S, Steinbrück L, Stanton R, Döring M, Lenac Rovis T, Kalinke U, Jonjic S, Moosmann A, Messerle M: Expression of the human cytomegalovirus UL11 glycoprotein in viral infection and evaluation of its effect on virus-specific CD8 T cells. Journal of Virology,  88(24):14326-39. doi: 10.1128/JVI.01691-14. 2014
  103. Brizić I, Lenac Roviš T, Krmpotić A, Jonjić S: MCMV avoidance of recognition and control by NK cells. Seminars in Immunopathology, 36(6):641-50. doi: 10.1007/s00281-014-0441-9. 2014
  104. Celis-Gutierrez J, Boyron M, Walzer T, Pandolfi PP, Jonjic S, Olive D, Dalod M, Vivier E, Nunès JA: Dok1 and Dok2 proteins regulate natural killer cell development and function. EMBO Journal, 33(17):1928-40. doi: 10.15252/embj.201387404. 2014
  105. Baird NL, Bowlin JL, Yu X, Jonjic S, Haas J, Cohrs RJ, Gilden D: Varicella zoster virus DNA does not accumulate in infected human neurons.Virology, 458-459:1-3. doi: 10.1016/j.virol.2014.04.014. 2014
  106. Crouse J, Bedenikovic G, Wiesel M, Ibberson M, Xenarios I, Von Laer D, Kalinke U, Vivier E, Jonjic S, Oxenius A: Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. Immunity, 40(6):961-73. doi: 10.1016/j.immuni.2014.05.003. 2014
  107. Slavuljica I, Kvestak D, Huszthy P, Kosmac K, Britt W, Jonjic S: Immunobiology of congenital cytomegalovirus infection of the central nervous system-the murine cytomegalovirus model. Cellular and Mollecular Immunology,  12(2):180-91. doi: 10.1038/cmi.2014.51. 2014
  108. Zarama A, Perez-Carmona N, Farre´ D, Tomic A, Borst EM, Messerle M, Jonjic S, Engel P, Angulo A: Cytomegalovirus m154 hinders CD48 cell-surface expression and promotes viral escape from host natural killer cell control. PLoS Pathogens, 10(3):e1004000. doi: 10.1371/journal.ppat.1004000. 2014
  109. Trilling M, Le VT, Rashidi-Alavijeh J, Katschinski B, Scheller J, Rose-John S, Androsiac GE, Jonjic S, Poli V, Pfeffer K, Hengel H: ‘Activated’ STAT proteins: a paradoxical consequence of inhibited JAK-STAT signalling in cytomegalovirus-infected cells. Journal of Immunology, 192(1):447-58. doi: 10.4049/jimmunol.1203516. 2014
  110. Geyer H, Hartung E, Mages HW, Weise C, Beluzic R, Vugrek O, Jonjic S, Kroczek RA, Voigt S: Cytomegalovirus expresses the chemokine homologue vXCL1 capable of attracting XCR1+CD4- dendritic cells. Journal of Virology, 88(1):292-302. doi: 10.1128/JVI.02330-13. 2014
  111. Cekinovic D, Lisnic VJ, Jonjic S: Rodent models of congenital cytomegalovirus infection. Methods in molecular Biology, 1119:289-310. doi: 10.1007/978-1-62703-788-4_16. 2014
  112. Trsan T, Busche A, Abram M, Wensveen FM, Lemmermann NA, Arapovic M, Babic M,Tomic A, Golemac M, Brinkmann MM, Jäger W, Oxenius A, Polic B, Krmpotic A, Messerle M, Jonjic S: Superior induction and maintenance of protective CD8 T cells in mice infected with mouse cytomegalovirus vector expressing RAE-1γ. Proceedings of the National Academy of Sciences of the United States of America, 110(41):16550-5. doi: 10.1073/pnas.1310215110. 2013
  113. Juranic Lisnic V, Babic Cac M, Lisnic B, Trsan T, Mefferd A, Mukhopadhyay CD, Cook CH, Jonjic S, Trgovcich J: Dual analysis of the murine cytomegalovirus and host cell transcriptomes reveal new aspects of the virus-host cell interface. PLoS Pathogens, 9(9):e1003611. doi: 10.1371/journal.ppat.1003611. 2013
  114. Wensveen MF, Lenartic M, Jelencic V, Lemmermann AN,  ten Brinke A, Jonjic S, Polic   B: NKG2D induces Mcl-1 expression and mediates survival of CD8 memory T cell precursors via phosphatidylinositol 3-kinase. Journal of Immunology,  191(3):1307-15. doi: 10.4049/jimmunol.1300670. 2013
  115. Jordan S, Ruzsics Z, Mitrović M, Baranek T, Arapović J, Krmpotić A, Vivier E, Dalod M, Jonjić S, Döelken L, Koszinowski UH: Natural killer cells are required for extramedullary hematopoiesis following murine cytomegalovirus infection. Cell Host & Microbe, 13(5):535-545. doi: 10.1016/j.chom.2013.04.007. 2013
  116. Stanietsky N, Roviš TL, Glasner A, Seidel E, Tsukerman P, Yamin R, Enk J, Jonjic S, Mandelboim O: Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR. European Journal of Immunology, 43(8):2138-50. doi: 10.1002/eji.201243072. 2013
  117. Lenac Rovis T, Bailer SM, Pothineni VR, Ouwendijk WJ, Simic H, Babic M, Miklic K, Malic S, Verweij MC, Baiker A, Gonzalez O, von Brunn A, Zimmer R, Früh K, Verjans GM, Jonjic S, Haas J: A comprehensive analysis of varicella zoster virus proteins using a new monoclonal antibody collection. Journal of Virology, 87(12):6943-6954. doi: 10.1128/JVI.00407-13. 2013
  118. Miletić A, Krmpotić A, Jonjić S: The evolutionary arms race between NK cells and viruses: Who gets the short end of the stick? European Journal of Immunology, 43(4):867-77. doi: 10.1002/eji.201243101. 2013
  119. Lankry D, Lenac Rovis T, Jonjic S, Mandelboim O: The interaction between CD300a and phosphatidylserine inhibits tumor cell killing by NK cells. European Journal of Immunology, 43(8):2151-61. doi: 10.1002/eji.201343433. 2013
  120. Kosmac K, Bantug R, Pugel E, Cekinovic D, Jonjic S, Britt WJ: Glucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development. PLoS Pathogens, 9(3):e1003200. doi: 10.1371/journal.ppat.1003200. 2013
  121. Handke W, Luig C, Popovic B, Krmpotic A, Jonjic S, Brune W: Viral inhibition of BAK promotes murine cytomegalovirus dissemination to salivary glands. Journal of Virology, 87(6):3592-6. doi: 10.1128/JVI.02657-12. 2013
  122. Wensveen FM, Klarenbeek PL, van Gisbergen K, Pascutti MF, Derks I, van Schaik B, ten Brinke A, de Vries N, Cekinovic D, Jonjic S, van Lier R, Eldering E: Pro-apoptotic protein Noxa regulates memory T cell population size and protects against lethal immunopathology. Journal of Immunology, 190(3):1180-91. doi: 10.4049/jimmunol.1202304. 2013
  123. Borst M, Kleine-Albers J, Gabaev I, Babic M, Wagner K, Binz A, Degenhardt I, Kalesse M, Jonjic S, Bauerfeind R, Messerle M: The human cytomegalovirus UL51 protein is essential for viral genome cleavage-packaging and interacts with the terminase subunits pUL56 and pUL89. Journal of Virology, 87(3):1720-32. doi: 10.1128/JVI.01955-12. 2013
  124. Yu X, Seitz S, Pointon T, Bowlin J, Cohrs R, Jonjic S, Haas J, Wellish M, Gilden D: Varicella zoster virus infection of highly pure terminally differentiated human neurons. Journal of Neurovirology, 19(1):75-81. doi: 10.1007/s13365-012-0142-x. 2013
  125. Mitrovic M, Arapovic J, Traven L, Krmpotic A, Jonjic S: Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8+ T cells during MCMV infection. Medical Microbiology and Immunology, 201(4):487-95. doi: 10.1007/s00430-012-0263-0. 2012
  126. Rodrıguez-Martin S, Kropp K, Wilhelmi V, Juranic Lisnic V,Yuan Hsieh W, Blanc M, Livingston A, Busche A, Tekotte H, Messerle M, Auer M, Fraser I, Jonjic S, Angulo A, Reddehase M, Ghazal P: Ablation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute Infection. PLoS Pathogens, 8(8):e1002901. doi: 10.1371/journal.ppat.1002901. 2012
  127. van Gisbergen K, Kragten N, Hertoghs K, Wensveen F, Jonjic S, Hamann J, Nolte M, van Lier R: Mouse Hobit is a homolog of the transcriptional repressor Blimp-1 that regulates NKT cell effector differentiation. Nature Immunology, 13(9):864-71. doi: 10.1038/ni.2393. 2012
  128. Mandaric S, Walton S, Ruelicke T, Richter K, Girard-Madoux M, Clausen B, Zurunic A, Kamanaka M, Flavell R, Jonjic S, Oxenius A: IL-10 suppression of NK/DC crosstalk leads to poor priming of MCMV-specific CD4 T cells and prolonged MCMV persistence. PLoS Pathogens, 8(8):e1002846. doi: 10.1371/journal.ppat.1002846. 2012
  129. Glasner A, Zurunic A, Meningher T, Lenac Rovis T, Tsukerman P, Bar-On Y, Yamin R, Meyers A, Mandeboim M, Jonjic S, Mandelboim O: Elucidating the mechanisms of influenza virus recognition by Ncr1. PLoS One, 7(5):e36837. doi: 10.1371/journal.pone.0036837. 2012
  130. Poglitsch, M, Weichhart T, Hecking M, Werzowa J, Katholnig K, Antlanger M, Krmpotic A, Jonjic S, Hörl W, Zlabinger G, Puchhammer E, Säemann M: CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages. American Journal of Transplantation, 12(6):1458-68. doi: 10.1111/j.1600-6143.2012.04002.x. 2012
  131. Mitrović M, Arapović J, Jordan S, Fodil-Cornu N, Ebert S, Vidal SM, Krmpotić A, Reddehase MJ, Jonjić S: The NK-cell response to mouse cytomegalovirus infection affects the level and kinetics of the early CD8(+) T-cell response. Journal of Virology, 86(4):2165-75. doi: 10.1128/JVI.06042-11. 2012
  132. Marcinowski L, Tanguy M, Krmpotic A, Rädle B, Juranic Lisnic V, Tuddenham L, Chane-Woon-Ming B, Ruzsics Z, Erhard F, Benkartek C, Babic M, Zimmer R, Trgovcich J, Koszinowski U, Jonjic S, Pfeffer S, Dölken L: Degradation of cellular miR-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo. PLoS Pathogens, 8(2):e1002510. doi: 10.1371/journal.ppat.1002510. 2012
  133. Slavuljica I, Krmpotić A, Jonjić S: Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response. Frontiers in Immunology, 2:85. doi: 10.3389/fimmu.2011.00085. 2011
  134. Kropp KA, Robertson KA, Sing G, Rodriguez-Martin S, Blanc M, Lacaze P, Noor Hassim MF, Khondoker MR, Busche A, Dickinson P, Forster T, Strobl B, Mueller M, Jonjic S, Angulo A, Ghazal P: Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state. Journal of Virology, 85(19):10286-99. doi: 10.1128/JVI.00373-11. 2011
  135. Jordan S, Krause J, Prager A, Mitrovic M, Jonjic S, Koszinowski UH, Adler B: Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary Glands due to a fixed mutation of MCK-2. Journal of Virology, 85(19):10346-53. doi: 10.1128/JVI.00545-11. 2011
  136. Babić M, Krmpotić A, Jonjić S: All is fair in virus-host interactions: NK cells and cytomegalovirus. Trends in Molecular Medicine, 17(11):677-85. doi: 10.1016/j.molmed.2011.07.003. 2011
  137. Pyzik M, Charbonneau B, Gendron-Pontbriand EM, Babic M, Krmpotic A, Jonjic S, Vidal S: Distinct MHC class I-dependent NK cell-activating receptors control cytomegalovirus infection in different mouse strains. Journal of Experimental Medicine, 208(5):1105-17. doi: 10.1084/jem.20101831. 2011
  138. Jonjic S, Trsan T: Resistance to mousepox virus: CD94 on a special mission. Immunity, 34(4):458-60. doi: 10.1016/j.immuni.2011.04.002. 2011
  139. Jovanovic I, Radosavljevic G, Mitrovic M, Lisnic Juranic V, McKenzie A, Arsenijevic N, Jonjic S, Lukic M: ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma. European Journal of Immunology, 41(7):1902-12. doi: 10.1002/eji.201141417. 2011
  140. Radosavljevic G, Jovanovic I, Majstorovic I, Mitrovic M, Lisnic VJ, Arsenijevic N, Jonjic S, Lukic ML: Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity. Clinical and Experimental Metastasis, 28(5):451-62. doi: 10.1007/s10585-011-9383-y. 2011
  141. Colonna M, Jonjic S, Watzl C: Natural Killer cells: fighting viruses and much more. Nature Immunology, 12(2):107–10. doi: 10.1038/ni0211-107. 2011
  142. Slavuljica I, Busche A, Babić M, Mitrović M, Gasparović I, Cekinović Dj, Markova Car E, Pernjak Pugel E, Ciković A, Juranić Lisnić V, Britt WJ, Koszinowski U, Messerle M, Krmpotić A, Jonjić S: Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. Journal of Clinical Investigation, 120(12):4532-45. doi: 10.1172/JCI43961. 2010
  143. Babic M, Pyzik M, Zafirova B, Mitrovic M, Butorac V, Lanier LL, Krmpotic A, Vidal SM Jonjic S: Cytomegalovirus immunoevasin reveals the physiological role of ”missing self” recognition in NK cell dependent virus control in vivo. Journal of Experimental Medicine, 207(12):2663-73. doi: 10.1084/jem.20100921. 2010
  144. Doelken L, Krmpotic A, Koethe S, Tuddenham L, Tanguy M, Marcinowska L, Ruzsics Z, Elefant N, Altuvia Y, Margalit H, Koszinowski U, Jonjic S, Pfeffer S: Cytomegalovirus microRNAs facilitate persistant virus infection in salivary glands. PloS Pathogens, 6(10):e1001150. doi: 10.1371/journal.ppat.1001150. 2010
  145. Lankry D, Simic H, Klieger Y, Levi-Schaffer F, Jonjic S, Mandelboim O: Expression and function of CD300 in NK cells. Journal of Immunology, 185(5):2877-86. doi: 10.4049/jimmunol.0903347. 2010
  146. Steer B, Adler B, Jonjic S, Stewart J, Adler H: A gammaherpesvirus complement regulatory protein promotes initiation of infection by activation of protein kinase Akt/PKB. PLoS One, 5(7):e11672. doi: 10.1371/journal.pone.0011672. 2010
  147. Champsaur M, Beilke JN, Ogasawara K, Koszinowski UH, Jonjic S, Lanier LL: Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1. Journal of Immunology, 185(1):157-65. doi: 10.4049/jimmunol.1000397. 2010
  148. Lisnić VJ, Krmpotić A, Jonjić S: Modulation of natural killer cell activity by viruses. Current Opinion in Microbiology, 13(4):530-9. doi: 10.1016/j.mib.2010.05.011. 2010
  149. Jonjic S: Functional plasticity and robustness are essential characteristics of biological systems: lessons learned from KLRG1 deficient mice. European Journal of Immunology, 40(5):1241-3. doi: 10.1002/eji.201040506. 2010
  150. Zhi L, Mans J, Paskow M, Brown PH, Schuck P, Jonjic S, Natarajan K, Margulies DH: Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms. Biochemistry, 49(11):2443-53. doi: 10.1021/bi902130j. 2010
  151. Stanietsky N, Simic H, Arapovic J, Toporik A, Levy O, Novik A, Levine Z, Beiman M, Dassa L, Achdout H, Stern-Ginossar N, Tsukerman P, Jonjic S, Mandelboim O: The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America, 106(42):17858-63. doi: 10.1073/pnas.0903474106. 2009
  152. Arapovic J, Lenac T, Antulov R, Polic B, Ruzsics Z, Carayannopoulos LN, Koszinowski UH, Krmpotic A, Jonjic S: Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus. Journal of Virology, 83(16):8198-207. doi: 10.1128/JVI.02549-08. 2009
  153. Zafirova B, Mandarić S, Antulov R, Krmpotić A, Jonsson H, Yokoyama WM, Jonjić S, Polić B: Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity, 31(2):270-82. doi: 10.1016/j.immuni.2009.06.017. 2009
  154. Dölken L, Jonjic S: All for one and one for all: herpesviral microRNAs close in on their prey. Cell Host Microbe, 5(4):315-7. doi: 10.1016/j.chom.2009.03.009. 2009
  155. Arapović J, Lenac Rovis T, Reddy AB, Krmpotić A, Jonjić S: Promiscuity of MCMV immunoevasin of NKG2D: m138/fcr-1 down-modulates RAE-1epsilon in addition to MULT-1 and H60. Molecular Immunology, 47(1):114-22. doi: 10.1016/j.molimm.2009.02.010. 2009
  156. Kielczewska A, Pyzik M, Sun T, Krmpotic A, Lodoen MB, Munks MW, Babic M, Hill AB, Koszinowski UH, Jonjic S, Lanier LL,Vidal SM: Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. Journal of Experimental Medicine, 206(3):515-23. doi: 10.1084/jem.20080954. 2009
  157. Budt M, Niederstadt L, Valchanova RS, Jonjić S, Brune W: Specific inhibition of the PKR-mediated antiviral response by the murine cytomegalovirus proteins m142 and m143. Journal of Virology, 83(3):1260-70. doi: 10.1128/JVI.01558-08. 2009
  158. Jonjić S, Polić B, Krmpotić A: Viral inhibitors of NKG2D ligands: Friends or foes of immune surveillance? European Journal of Immunology, 38(11):2952-6. doi: 10.1002/eji.200838823. 2008
  159. Jonjic S, Krmpotic A, Arapovic J, Koszinowski UH: Dissection of the antiviral NK cell response by MCMV mutants. Methods in Molecular Biology, 415:127-49. doi: 10.1007/978-1-59745-570-1_8. 2008
  160. Cekinovic D, Golemac M, Pugel EP, Tomac J, Cicin-Sain L, Slavuljica I, Bradford R, Misch S, Winkler TH, Mach M, Britt WJ, Jonjic S: Passive immunization reduces murine cytomegalovirus-induced brain pathology in newborn mice. Journal of Virology, 82(24):12172-80. doi: 10.1128/JVI.01214-08. 2008
  161. Lenac T, Arapović J, Traven L, Krmpotić A, Jonjić S: Murine cytomegalovirus regulation of NKG2D ligands. Medical Microbiology and Immunology, 197(2):159-66. doi: 10.1007/s00430-008-0080-7. 2008
  162. Bantug G, Cekinovic D, Bradford R, Koontz T, Jonjic S, Britt WJ: CD8+ T lymphocytes control murine cytomegalovirus replication in the central nervous system of newborn animals. Journal of Immunology, 181(3):2111-23. doi: 10.4049/jimmunol.181.3.2111. 2008
  163. Cicin-Sain L, Ruzsics Z, Podlech J, Bubić I, Menard C, Jonjić S, Reddehase MJ, Koszinowski UH: Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an anti-apoptotic viral gene. Journal of Virology, 82(5):2056-64. doi: 10.1128/JVI.01803-07. 2008
  164. Jonjić S, Babić M, Polić B, Krmpotić A: Immune evasion of natural killer cells by viruses. Current Opinion in Immunology, 20(1):30-8. doi: 10.1016/j.coi.2007.11.002. 2008
  165. Koontz T, Bralic M, Tomac J, Pernjak-Pugel E, Bantug G, Jonjic S, Britt WJ: Altered development of the brain after focal herpesvirus infection of the central nervous system. Journal of Experimental Medicine, 205(2):423-35. doi: 10.1084/jem.20071489. 2008
  166. Cicin-Sain L, Bubic I, Schnee M, Ruzsics Z, Mohr C, Jonjic S, Koszinowski UH: Targeted deletion of regions rich in immune evasive genes from the cytomegalovirus genome as novel vaccine strategy. Journal of Virology,81(24):13825-34. doi: 10.1128/JVI.01911-07. 2007
  167. Mans J, Natarajan K, Balbo A, Schuck P, Eikel D, Hess S, Robinson H, Simic H, Jonjic S, Tiemessen CT, Margulies DH: Cellular Expression and Crystal Structure of the Murine Cytomegalovirus MHC-Iv Glycoprotein, m153. Journal of Biological Chemistry, 282(48):35247-58. doi: 10.1074/jbc.M706782200. 2007
  168. Klenovsek K, Weisel F, Schneider A, Appelt U, Jonjic S, Messerle M, Bradel-Tretheway B, Winkler TH, Mach M: Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells. Blood, 110(9):3472-9. doi: 10.1182/blood-2007-06-095414. 2007
  169. Lenac T, Budt M, Arapovic J, Hasan M, Zimmermann A, Simic H, Krmpotic A, Messerle M, Ruzsics Z, Koszinowski UH, Hengel H, Jonjic S: The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. Journal of Experimental Medicine, 203(8):1843-50. doi: 10.1084/jem.20060514. 2006
  170. Girard Adam S, Caraux A, Fodil-Cornu N, Concepcion Loredo-Osti J, Lesjean-Pottier S, Jaubert J, Bubic I, Jonjic S, Guénet J, Vidal S, Colucci F: Cmv4, a new locus linked to the natural killer cell gene complex, controls innate resistance to cytomegalovirus in wild-derived mice. Journal of Immunology, 176(9):5478-85. doi: 10.4049/jimmunol.176.9.5478. 2006
  171. Buch T, Polic B, Clausen BE, Weiss S, Akilli-Ozturk O, Chang C-H, Flavell R, Schulz A, Jonjic S, Waisman A, Förster I: MHC class II expression through a hitherto unknown pathway supports T helper cell dependent immune responses: implications for MHC class II deficiency. Blood, 107(4):1434-44. doi: 10.1182/blood-2004-09-3445. 2006
  172. Strobl B, Bubic I, Bruns U, Steinborn R, Laiko R, Kolbe T, Karaghiosoff M, Kalinke U, Jonjic S, Müller M: Novel functions of Tyk2 in the antiviral defense against murine cytomegalovirus. Journal of Immunology, 175(6):4000-4008. doi: 10.4049/jimmunol.175.6.4000. 2005
  173. Zimmermann A, Trilling M, Wagner M, Wilborn M, Bubic I, Jonjic S, Koszinowski UH, Hengel H: A cytomegaloviral protein reveals a dual role for STAT2 in IFN-γ signaling and antiviral responses. Journal of Experimental Medicine, 201(10):1543-53. doi: 10.1084/jem.20041401. 2005
  174. Krmpotic A, Hasan M, Loewendorf A, Saulig T, Halenius A, Lenac T, Polic B, Bubic I, Kriegeskorte A, Pernjak Pugel E, Messerle M, Hengel H, Busch D, Koszinowski UH, Jonjic S: NK cell activation through the NKG2D ligand Mult-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. Journal of Experimental Medicine, 201(2):211-220. doi: 10.1084/jem.20041617. 2005
  175. Hasan M, Krmpotic A, Ruzsics Z, Bubic I, Lenac T, Halenius A, Loewendorf A, Messerle M, Hengel H, Jonjic S, Koszinowski UH: Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. Journal of Virology, 79(5):2920-2930. doi: 10.1128/JVI.79.5.2920-2930.2005. 2005
  176. French AR, Pingel JT, Wagner M, Bubic I, Yang L, Kim S, Koszinowski UH, Jonjic S, Yokoyama WM: Escape of mutant double-straned DNA virus from innate immune control. Immunity, 20:747-756. doi: 10.1016/j.immuni.2004.05.006. 2004
  177. Bubic I, Wagner M, Krmpotic A, Saulig T, Kim S, Yokoyama WM, Jonjic S, Koszinowski UH: Gain-of-Virulence Caused by Loss of a Gene in Murine Cytomegalovirus. Journal of Virology, 78:7536-7544. doi: 10.1128/JVI.78.14.7536-7544.2004 2004
  178. Jonjic S, Traven L: Small countries receive even less of a fair deal. Nature, 429(6992):601-601. doi: 10.1038/429601a. 2004
  179. Krmpotic A, Bubic I, Polic B, Lucin P, Jonjic S: Pathogenesis of murine cytomegalovirus infection. Microbes and Infection, 5:1263-1277. doi: 10.1016/j.micinf.2003.09.007. 2003
  180. Cicin-Sain L, Brune W, Bubic I, Jonjic S, Koszinowski UH: Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo. Journal of Virology, 77:8249-8255. doi: 10.1128/jvi.77.15.8249-8255.2003. 2003
  181. Hasan M, Polic B, Bralic M, Jonjic S, Rajewsky K: Incomplete block of B cell development and immunoglobulin production in mice carrying the muMT mutation on the BALB/c background. European Journal of Immunology, 32:3463-3471. doi: 10.1002/1521-4141(200212)32:12<3463::AID-IMMU3463>3.0.CO;2-B. 2002
  182. Krmpotic A, Busch D, Bubic I, Gebhardt F, Hengel H, Hasan M, Scalzo A, Koszinowski UH, Jonjić S: MCMV glycoprotein gp40 confers virus resistance to CD8+T cells and NK cells in vivo. Nature Immunology, 3:529-35. doi: 10.1038/ni799. 2002
  183. Brune W, Hasan M, Krych M, Bubic I, Jonjic S, Koszinowski UH: Secreted Virus – Encoded Proteins Reflect Murine Cytomegalovirus productivity in Organs. Journal of Infectious Diseases, 184:1320-4. doi: 10.1086/323993. 2001
  184. Trgovcich J, Stimac D, Polic B, Krmpotic A, Pernjak-Pugel E, Tomac J, Hasan M, Wreber B, Jonjic S: Immune responses and cytokine induction in the development of severe hepatitis during acute infections with murine cytomegalovirus. Archives of Virology, 145:1-18. doi: 10.1007/s007050070010. 2000
  185. Wagner M, Michel D, Schaarschmidt P, Vaida B, Jonjic S, Messerle M, Mertens T, Koszinowski UH: Comparison between Human Cytomegalovirus pUL97 and Murine Cytomegalovirus (MCMV) pM97 Expressed by MCMV and Vaccinia Virus: pM97 Does Not Confer Ganciclovir Sensitivity. Journal of Virology, 74:10729-10736. doi: 10.1128/jvi.74.22.10729-10736.2000. 2000
  186. Wagner M, Jonjic S, Koszinowski UH, Messerle M: Systematic Excision of Vector Sequences from the BAC-Cloned Herpesvirus Genome during Virus Reconstitution. Journal of Virology, 73:7056-7060. doi: 10.1128/JVI.73.8.7056-7060.1999. 1999
  187. Krmpotic A, Messerle M, Crnkovic-Mertens I, Polic B, Jonjic S, Koszinowski UH: The Immunoevasive Function Encoded by the Mouse Cytomegalovirus Gene m152 protects the Virus against T Cell Control in Vivo. Journal of Experimental Medicine, 190:1285-1295. doi: 10.1084/jem.190.9.1285. 1999
  188. Markotic A, Lümen R, Marusic A, Jonjic S, Müthing J: Ganglioside expression in tissues of mice lacking the tumor necrosis factor receptor 1. Carbohydrate Research, 321:75-87. doi: 10.1016/s0008-6215(99)00171-8. 1999
  189. Hengel H, Reusch U, Gutermann A, Ziegler H, Jonjic S, Lucin P, Koszinowski UH: Cytomegaloviral control of MHC class I function in the mouse. Immunological Reviews, 168:167-176. doi: 10.1111/j.1600-065x.1999.tb01291.x. 1999
  190. Knezevic N, Nikolic B, Brajsa K, Spaventi R, Jonjic N, Jonjic S, Marusic S: Monoclonal Antibodies Against Maternal Major Histocompatibility Complex Class I Molecules Induce Rapid Abortion in Mice. Journal of Reproductive Immunology, 41:217-223. doi: 10.1111/j.1600-0897.1999.tb00535.x. 1999
  191. Polic B, Hengel H, Krmpotic A, Trgovcich J, Pavic I, Lucin P, Jonjic S, Koszinowski UH: Hierarchical and Redundant Lymphocyte Subset Control Precludes Cytomegalovirus Replication during Latent Infection. Journal of Experimental Medicine, 188:1047-1054. doi: 10.1084/jem.188.6.1047. 1998
  192. Trgovcich J, Pernjak-Pugel E, Tomac J, Koszinowski UH, Jonjic S: Pathogenesis of Murine Cytomegalovirus Infection in Neonatal Mice. Monographs in Virology, Basel, Karger, 21:42-53. doi:10.1159/000061689. 1998
  193. Crnkovic-Mertens I, Messerle M, Milotic I, Szepan U, Kucic N, Krmpotic A, Jonjic S, Koszinowski UH: Virus Attenuation after Deletion of the Cytomegalovirus Fc Receptor Gene Is Not due to Antibody Control. Journal of Virology, 72(2):1377-1382. doi: 10.1128/JVI.72.2.1377-1382.1998. 1998
  194. Rukavina T, Ticac B, Susa M, Jendrike N, Jonjic S, Lucin P, Marre R, Doric M, Trautmann M: Protective Effect of Antilipopolysaccharide Monoclonal Antibody in Experimental Klebsiella Infection. Infection and Immunity, 65(5):1754-1760. doi: 10.1128/iai.65.5.1754-1760.1997. 1997
  195. Polic B, Jonjic S, Pavic I, Crnkovic I, Zorica I, Hengel H, Lucin P, Koszinowski UH: Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo. Journal of General Virology, 77:217-225. doi: 10.1099/0022-1317-77-2-217. 1996
  196. Marusic A, Katavic V, Stimac D, Kusec V, Jonjic S: Bone turnover in homozygous b2-microglobuline knock-out mice does not differ from that in their heterozygous littermates. European Journal of Clinical Chemistry and Clinical Biochemistry, 33:915-918. doi: 10.1515/cclm.1995.33.12.915. 1995
  197. Polic B, Jonjic S, Pavic I, Crnkovic I, Dujmovic M, Zorica I, Hengel H, Kucic N, Lucin P, Koszinowski UH: Control of cytomegalovirus infection in MHC class I deficient mice. Scandinavian Journal of Infectious Diseases, Suppl. 99:52-53. 1995
  198. Lucin P, Jonjic S, Hengel H, Pavic I, Polic B, Crnkovic I, Thäle R, Zorica I, Koszinowski U H: Cytomegalovirus persistence in salivary glands by evasion from immunological control. Regional Immunology, 6:391-397. 1995
  199. Koszinowski UH, Jonjic S, Lucin P: Cytomegalovirus persistence by evasion from immune control. Seminars in Virology, 5:297-305. 1994
  200. Jonjic S, Pavic I, Polic B, Crnkovic I, Lucin P, Koszinowski UH: Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. Journal of Experimental Medicine, 179:1713-1717. doi: 10.1084/jem.179.5.1713. 1994
  201. Reddehase MJ, Balthesen M, Rapp M, Jonjic S, Pavic I, Koszinowski UH: The Conditions of Primary Infection Define the Load of Latent Viral Genome in Organs and the Risk of Recurrent Cytomegalovirus Disease. Journal of Experimental Medicine, 179:185-193. doi: 10.1084/jem.179.1.185. 1994
  202. Hengel H, Lucin P, Jonjic S, Ruppert T, Koszinowski UH: Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. Journal of Virology, 68:289-297. doi: 10.1128/JVI.68.1.289-297.1994. 1994
  203. Lucin P, Jonjic S, Messerle M, Polic B, Hengel H, Koszinowski UH: Late phase inhibition of murine cytomegalovirusreplication by synergic action of interferon‑gamma and tumor necrosis factor. Journal of General Virology, 75:101-110. doi: 10.1099/0022-1317-75-1-101. 1994
  204. Pavic I, Polic B, Crnkovic I, Lucin P, Jonjic S, Koszinowski UH: Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection. Journal of General Virology, 74:2215-2223. doi: 10.1099/0022-1317-74-10-2215. 1993
  205. Lucin P, Pavic I, Polic B, Jonjic S, Koszinowski UH: Gamma interferon‑dependent clearance of cytomegalovirus infection in salivary glands. Journal of Virology, 66:1977 – 1984. doi: 10.1128/JVI.66.4.1977-1984.1992. 1992
  206. Koszinowski UH, Reddehase MJ, Jonjic S: The role of CD4 and CD8 T cells in viral infections. Current Opinion in Immunology, 3:471 – 475. doi: 10.1016/0952-7915(91)90005-l. 1991
  207. Jonjic S, Pavic I, Lucin P, Rukavina D, Koszinowski UH: Efficacious control of cytomegalovirus infection after long‑term depletion of CD8+ T lymphocytes. Journal of Virology, 64:5457‑5464. doi: 10.1128/JVI.64.11.5457-5464.1990. 1990
  208. Jonjic S, Mutter W, Weiland F, Reddehase MJ, Koszinowski UH: Site‑restricted persistent cytomegalovirus infection after selective long‑term depletion of CD4‑positive T lymphocytes. Journal of Experimental Medicine, 169:1199‑1212. doi: 10.1084/jem.169.4.1199. 1989
  209. Koszinowski UH, Volkmer HJ, Messerle M, Jonjic S, Wittek R: Cytotoxic T lymphocytes induced by vaccinia recombinant expressing a herpesvirus nonstructural immediate ‑ early protein protect against cytomegalovirus infection. Vaccines, 88:41‑45. 1988
  210. Del Val M, Volmer MJ, Rothbard JB, Jonjic S, Messerle M, Schickedanz J, Reddehase MJ, Koszinowski UH: Molecular basis for cytolytic T lymphocyte recognition of the murine cytomegalovirus immediate early protein pp89. Journal of Virology, 62:3965‑3972. doi: 10.1128/JVI.62.11.3965-3972.1988. 1988
  211. Reddehase MJ, Jonjic S, Weiland F, Mutter W, Koszinowski UH: Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4 helper ‑ independent antiviral function of CD8 positive memory T lymphocyte derived from latently infected donors. Journal of Virology, 62:1061‑1065. doi: 10.1128/jvi.62.3.1061-1065.1988. 1988
  212. Jonjic S, del Val M, Keil GM, Reddehase MJ, Koszinowski UH: A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection. Journal of Virology, 62:1653‑1658. doi: 10.1128/jvi.62.5.1653-1658.1988 1988
  213. Nick S, Metzger B, Jonjic S, Falke D: Suppression of humoral antibody formation against sheep red blood cells by infections with HSV‑2 and influence of mouse cytomegalovirus. Archives of Virology, 97:131‑135. doi: 10.1007/BF01310741. 1987
  214. Koszinowski UH, Reddehase MJ, Keil GM, Volkmer HJ, Jonjic S, Messerle M, del Val M, Mutter W, MGnch K, Buhler B: Molecular analysis of herpesviral gene products recognized by protective cytolytic T lymphocytes. Immunology Letters, 16:185‑192. doi: 10.1016/0165-2478(87)90146-5. 1987
  215. Volkmer HJ, Bertholet C, Jonjic S, Wittek R, Koszinowski UH: Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate‑early protein pp89 expressed by recombinant vaccinia virus. Journal of Experimental Medicine, 166:668‑677. doi: 10.1084/jem.166.3.668. 1987
  216. Saalmuller A, Reddehase M, Bühring HJ, Jonjić S, Koszinowski UH: Simultaneous expression of CD4 and CD8 antigens by substantial proportion of resting porcine T lymphocytes. European Journal of Immunology, 17:1297‑1301. doi: 10.1002/eji.1830170912. 1987
  217. Jonjic S, Radosevic‑Stasic B, Cuk M, Jonjic N, Rukavina D: Class II antigens induction in the regenerating liver of rats after partial hepatectomy. Transplantation, 44:49‑54. 1987
  218. Jonjic N, Jonjic S, Saalmuller A, Rukavina D, Koszinowski UH: Distribution of T lymphocyte subsets in porcine lymphoid tissues. Immunology, 60:395‑401. 1987
  219. Saalmuller A, Jonjic S, Buhring HJ, Reddehase MJ, Koszinowski UH: Monoclonal antibodies reactive with swine lymphocytes. II. Detection of an antigen on resting T cells down‑regulated after activation. Journal of Immunology, 138:1852‑1857. 1987
  220. Doric M, Rukavina D, Jonjic S: Immune responsiveness in offsprings of adoptively immunized mothers. Immunobiology, 172:92‑98. doi: 10.1016/S0171-2985(86)80055-9. 1986
  221. Reddehase MJ, Weiland F, Munch K, Jonjic S, Lüske A, Koszinowski UH: Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. Journal of Virology, 55:264‑273. doi: 10.1128/JVI.55.2.264-273.1985. 1985
  222. Doric M, Rukavina D, Jonjic S: Increase in the number of plaque‑forming cells in the spleen of newborns from adoptively immunied mothers. Folia Biologica, 30:141‑144. 1984
  223. Jonjic S, Koszinowski UH: Monoclonal antibodies reactive with swine lymphocytes I. Antibodies to membrane structures that define the cytolytic T lymphocyte subset in the swine. Journal of Immunology, 133:647‑652. 1984
Croatian journals publications
  1. Skenderi F, Jonjic S.: Viral vaccines and vectors – some lessons from cytomegaloviruses. Periodicum Biologorum, 114, 2, 201-210. 2012
  2. Kucic N, Jonjic S, Koszinowski UH, Lucin P: Characterization of murine cytomegalovirus 34 kDa glycoprotein that forms a complex with the cell surface MHC class I molecules. Periodicum Biologorum, 100, 4:469-476. 1998
  3. Jonjic S, Lucin P: The Science at Croatian Universities: A Gloomy View through SCIsearch and MEDLINE, Croatian Medical Journal , 37:2-6. 1996
  4. Lucin P, Jonjic S: How to organize postgraduate study? A model. Periodicum Biologorum, 97:4; 1995
  5. Lucin P, Jonjic S: Cytomegalovirus replication cycle: an overview. Periodicum Biologorum, 97:1. 1995
  6. Polic B, Pavic I, Crnkovic I, Lucin P, Trobonjaca Z, Jonjic S: The role of CD4+ and CD8+ T lymphocytes in viral immunity. Croatian Medical Journal, 34:294-300. 1993
  7. Lucin P, Polic B, Crnkovic I, Lucin K, Rukavina D, Jonjic S: Involvement of CD4+ T lymphocytes and macrophages in the low‑dose streptozotocin‑induced diabetes in CBA mice. Croatian Medical Journal, 33:9 – 16. 1992
  8. Jonjic S, Pavic I, Lucin P, Grkovic I, Rukavina D: The role of T lymphocyte subsets in the control of cytomegalovirus infection. Periodicum Biologorum, 29:23‑24. 1990
  9. Lucin P, Rukavina D, Crnkovic I, Tomac J, Jonjic S: Effect of L3T4 and/or Lyt‑2 T‑cell depletion on low‑dose streptozotocin‑induced diabetes in mice. Periodicum Biologorum, 92:95‑95. 1990
  10. Jonjic S, Karboun A T, Susa M, Lucin P, Haller H, Jonjićc N, Rukavina D: The role of CD4+ and CD8+ T‑cell subsets in the rejection of the tumor allograft. Iugoslavica physiologica et pharmacologica acta, 24:157‑158. 1989
  11. Zec J, Orlic P, Matic‑Glazar D, Dimec D, Velcic G, Zelic M, Uravic M, Vukas D, Cohar F, Vujaklija‑Stipanovic K, Miculinic‑Ivancic E, Crnic‑Martinovic M, Jonjic S, Rukavina D, Sepic A: 14 years of kidney transplantation in Rijeka. Periodicum Biologorum, 88(Suppl.1/A):90‑91. 1986
  12. Manestar D, Matutinovic T, Jonjic S, Rukavina D, Gjuraj C: Immune competence of tonsillar lymphocytes in children undergoing tonsillectomy. Periodicum Biologorum, 88(Suppl.1/A):254‑255. 1986
  13. Orlic P, Jonjic S, Matic‑Glazar D, Grzetic M, Zec J, Rukavina D: Immune competence in patients under immunosuppressive therapy with CsA. Periodicum Biologorum, 88(Suppl.1/A):567‑568. 1986
  14. Vujaklija‑Stipanovic K, Doric M, Crnic‑Martinovic M, Fucak M, Jonjic S, Cuk M, Polic L, Sepic A, Rukavina D: Spontaneous development of donor‑specific tolerance in renal allograft recipients. Periodicum Biologorum, 88(Suppl.1/A):575‑576. 1986
  15. Jonjic S, Vujaklija‑Stipanovic K, Fucak M, Cuk M, Kapovic M, Crnic M, Matic‑Glazar D, Rukavina D: Immune competence in long‑term renal allograft recipients. Periodicum Biologorum, 88(Suppl.1/A):76‑ 77. 1986
  16. Jonjic S, Pavlica N, Doric M, Rukavina D: Investigation of the immunoregulatory potential of fetal and neonatal spleen and liver cells in rats. Periodicum Biologorum, 88:319‑324. 1986
  17. Jonjic S, Jonjic N, Rukavina D: Perspektiva imunosupresivne terapije monoklonskim protutijelima koja prepoznaju diferencijacijske antigene na T limfocitima. Acta Facultatis Medicae Fluminensis, 11 (3-4) 102-107. 1986
  18. Jonjic S, Rukavina D: Maternal and offspring alloimmunisation during pregnancy in sheep. Periodicum Biologorum, 87:355‑360. 1986
  19. Doric M, Rukavina D, Jonjic S: Increase in the number of plaque‑forming cells in the spleen of newborns from adoptively immunied mothers. Folia Biologica, 30:141‑144. 1984
  20. Kapovic M, Rukavina D, Jonjic S, Nemarnik J: Effect of multiparity on immune response in rat. Periodicum Biologorum, 85(Suppl.3):89‑90. 1983
  21. Radosevic‑Stasic B, Jonjic S, Polic L, Rukavina D: Immune response of rats after pharmacological pinealectomy. Periodicum Biologorum, 85(Suppl.3):119‑121. 1983
  22. Doric M, Jonjic S, Rukavina D: Immunological activity of lymphoid organs in pregnant rats. Periodicum Biologorum, 85 (Suppl.3):87‑88. 1983
  23. Jonjic S, Doric M, Rukavina D: Regulation of the immunological response to mitogens and allogeneic cells by fetal liver and spleen cells. Periodicum Biologorum, 85(Suppl.3):21‑22. 1983
  24. Doric M, Rukavina D, Jonjic S: Immune response in offsprings of adoptively immunized mothers. Iugoslavica physiologica et pharmacologica acta, 19:27‑28. 1983
  25. Jonjic S, Rukavina D: Immunoregulation with foetal and neonatal liver and spleen cells. Iugoslavica physiologica et pharmacologica acta, 19:69‑73. 1983
  26. Rukavina D, Jonjić S: The effects of the transplacental traffic of lymphocytes. Periodicum Biologorum, 78 (Suppl.1) 65‑66. 1976

Book Chapters

  1. Brizić I, Lisnić B, Brune W, Hengel H, Jonjić S: Cytomegalovirus infection: Mouse model. Current Protocols in Immunology. e51. doi: 10.1002/cpim.51. 2018
  2. Cekinovic D, Juranic Lisnic V, Jonjić S: Rodent models of congenital cytomegalovirus infection. Human Cytomegaloviruses, Methods and Protocols, Methods in Molecular Biology, editor: Andrew Yurochko, ISSN: 1064-3745, Volume 1119, pp.289-310, Humana Press, Springer, New York, 2014
  3. Vidal S, Krmpotic A, Pyzik M, Jonjic S: Innate Immunity to Cytomegalovirus in the Murine Model. Chapter II.9, Cytomegaloviruses From Molecular Pathogenesis to Intervention. editor: Matthias J. Reddehase, ISBN: 978-1-908230-18-8, pp.192-214, Caister Academic Press, Germany, 2013
  4. Britt W, Cekinovic D, Jonjic S: Murine Model of Neonatal Cytomegalovirus Infection. Chapter II.6, Cytomegaloviruses From Molecular Pathogenesis to Intervention. editor: Matthias J. Reddehase, ISBN: 978-1-908230-18-8, pp.119-141, Caister Academic Press, Germany, 2013
  5. Juranic Lisnic V, Gasparovic I, Krmpotic A, Jonjic S. Virus Interactions with NK Cell Receptors. Natural Killer Cells, editor: J. Zimmer, pp.125-152, Springer-Verlag, Berlin Heidelberg, 2009
  6. Cekinovic D, Slavuljica I, Lenac T, Krmpotic A, Polic B, Jonjic S: Innate Immunity to Mouse Cytomegalovirus. in National Institute of Allergy and Infectious Diseases, NIH: Frontiers in Research, editors: Vassil St. Georgiev, Karl A. Western, JJ McGowan, pp. 445-456. The Humana Press Inc., 2008
  7. Jonjic S, Krmpotic A, Arapovic J, Koszinowski UH.: Dissection of the Antiviral NK Cell Response by MCMV Mutants. in: Methods in Molecular Biology, vol. 415: Innate Immunity, editors: J. Ewbank and E. Vivier, pp.127-149, The Humana Press Inc., 2008
  8. Koszinowski UH, Jonjic S: Microbial Subversion of NK Cell Function. Chapter 2 in: Microbial Subversion of Immunity: Current Topics, editor: Peter Lachmann, pp.17-51, Caister Academic Press, 2006
  9. Jonjic S, Bubic I, Krmpotic A: Innate Immunity to Cytomegalovirus. in Cytomegaloviruses: Molecular Biology and Immunology, editor: Matthias J. Reddehase, pp.286-319, Caister Academic Press, 2005
  10. Jonjic S: Surgical removal of mouse salivary glands. Current Protocols in Immunology, editors: J. Coligan, A. Kruisbeek, D. Marguiles, E. Shevach & W. Strober, 1.11.1 – 1.11.4, John Wiley, New York; 2001
  11. Koszinowski UH, Reddehase MJ, Jonjic S: The role of T lymphocyte subsets in the control of cytomegalovirus infection. editors: Thomas BB, Marcel Dekker, pp.429 – 445, Viruses and the Cellular Immune Response Inc, N.Y., 1991
  12. Koszinowski UH, Jonjic S, Reddehase MJ: Pathogenesis of virus host interactions in vivo during CMV infection. Progress in Cytomegalovirus Research, editor: Landini MP, pp.277- 292, Elsevier, 1991
  13. Koszinowski UH, Reddehase MJ, del Val M, Munch K, Messerle M, Volkmer H, Jonjic S: Molecular analysis of the protective immune response to murine cytomegalovirus. Progress in Immunology vol. VII (Proc.of the 7th Int. Con. Immunol., Berlin 1989), pp.946-953., Springer, 1989
  14. Kapovic M, Rukavina D, Jonjic S: Interaction of fetuses and “placebo” fetus on systemic immune response. Immunology of Reproduction (Proc. of the Fifth Int. Symp.,Varna, Bulgaria, 1982), 191-194. Bulg. Acad. Sci. Press, Sofia, 1982
  15. Jonjic S, Rukavina D, Doric M, Kapovic M: Regulatory cells in fetal spleen and liver in rats and mice. Immunology of Reproduction (Proc. of the Fifth Int. Symp., Varna, Bulgaria,1982), 407-411. Bulg. Acad. Sci. Press, Sofia, 1982
  16. Jonjic S, Rukavina D: Materno fetal relationship and transplantation reactivity in the perinatal period of sheep. Immunology of Reproduction (Proc. of the Fourth Int.Symp., Varna, Bulgaria, 1979), pp. 646-650. Bulg. Acad. Sci. Press, Sofia, 1979

Translations and other publications

  1. Jonjic S: Immunity to microorganisms, Chapter 16, pp. 339-357; Jonjic S, Wensveen F: Immunity to tumors, Chapter 18, pp. 383-397; Cellular and molecular immunology, 8th edition (Abbas A, Lichtmann A, Pillai S):  editors: Drago Batinic, Vesna Lukinovic-Skudar, ISBN: 978-953-176-819-1, Medicinska naklada Zagreb, 2018
  2. Jonjic S, Krmpotic A: Cytomegalovirus pathogenesis – immunosurveillance and immunoevasion mechanisms involved. Bioinformatics and biological physics, Proceedings of the scientific meeting, editor: Vladimir Paar, Croatian academy of sciences and arts, 47-62, 2013
  3. Traven L, Razic E, Jonjic S: Local dealers deplete Croatian science funds. Periodicum Biologorum. 106, 4:473-475, 2005
  4. Jonjic S, Traven L: Small countries receive even less of a fair deal. Nature 10;429(6992):601, 2004
  5. Molecular biology in medicine, T.M. Cox. J.Sinclair (ed.) Croatian Edition: Jonjic S, Lucin P, Crnek-Kunstelj V and Traven L (ed.) Medicinska naklada, Zagreb, 2000
  6. Fiziologija (R.M. Berne i M.N. Levy, Translation: 42. and 43. chapter). Medicinska Naklada, Zagreb, 1993
  7. Dobi-Babic R, Katalinic P, Gudelj L, Jonjic S: Civilian Massacre in Lovinac. Croatian Medical Journal, (Warr Suppl. 1) 33:35-41, 1992
  • Center for Proteomics, Faculty of Medicine, University of Rijeka
Braće Branchetta 20, 51000 Rijeka, Croatia
University of Rijeka / Faculty of Medicine / Center for Proteomics

© Copyright 2023 | All rights reserved | Web development: Intraweb d.o.o.